OR WAIT null SECS
Pharmaceutical Technology
Randi Hernandez was science editor at Pharmaceutical Technology from September 2014 to May 2017.
February 12, 2015
Genzyme will partner with Voyager Therapeutics for the discovery, development, and commercialization of novel gene therapies for central nervous system disorders.
February 05, 2015
The deal may offset billions of dollars in waning sales from Pfizer drugs slated to lose patent protection and provides Pfizer with a whole portfolio of biosimilar products.
February 04, 2015
The cyclin-dependent kinase 4/6 inhibitor for the treatment of metastatic breast cancer was approved more than two months ahead of the prescription drug user fee goal date.
February 02, 2015
The 2016 White House Budget proposes a change to the data exclusivity period for biologics and the authority to influence drug pricing.
EMD Millipore will provide process development services for Precision Biologics’ preclinical monoclonal antibody.
New guidelines focused on the materials of construction in biologic therapy packaging will help vendors prepare comprehensive extractable and leachable testing strategies.